Nivolumab in Patients With Recurrent Malignant Mesothelioma

Clinical trial NCT02497508 · COMPLETED

Trial details

NCT number: NCT02497508
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2015-07-01
Primary completion: 2017-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.